With reimbursements falling and costs climbing, more independent physicians are asking: Do we partner, sell, or double down on staying solo? This piece lays out 10 strategic paths — from private equity and family offices to CINs, MSOs, health system deals, and “stay independent but scale up” — along with practical due-diligence questions on culture, debt, and “income repair.”
If you’re rethinking your practice’s future, this is a roadmap worth studying.

